Skip to main
CTOR

CTOR Earnings Dates & Reports

CTOR Most Recent Earnings

Report Date
Period EndingQ4 2025
Est. EPS-$0.06
Actual EPS-$0.06
EarningsMeet

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CTOR Earnings per Share (EPS) History

Signup for full access
Browse free

CTOR Latest Earnings

The value each CTOR share was expected to gain vs. the value each share gained.

CTOR reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$0.06. This exceeded analysts' expectations of -$0.06 by 0.00%, marking a Meet.

For comparison, Citius Oncology Inc reported EPS of -$0.14 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.04.

CTOR Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2026
-$0.04
Q4 2025
-$0.06-$0.060.00%
DeckReportListen
Q3 2025
-$0.08
DeckReportListen
Q2 2025
-$0.11
DeckReportListen
Q1 2025
-$0.09
DeckReportListen
View all

CTOR Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Citius Oncology Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

CTOR Earnings FAQs

CTOR last reported earnings on Dec 23, 2025 for Q4 2025, posting an EPS of -$0.06, which Meet the estimate of -$0.06 by 0.00%.

For Q4 2025, CTOR reported an EPS of -$0.06, missing analysts' estimate of -$0.06 by 0.00%.

For Q4 2025, CTOR Meet expectations with an actual EPS of -$0.06 vs. an estimated EPS of -$0.06.

Following the last earnings report on Dec 23, 2025, CTOR's stock price moved — from — to —.

The next CTOR earnings call is scheduled for Feb. 13, 2026, where executives will discuss financial results and outlook.

Citius Oncology Inc (CTOR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.